GB0110682D0 - Once-a-day pharmaceutical composition containing brivudine - Google Patents
Once-a-day pharmaceutical composition containing brivudineInfo
- Publication number
- GB0110682D0 GB0110682D0 GBGB0110682.2A GB0110682A GB0110682D0 GB 0110682 D0 GB0110682 D0 GB 0110682D0 GB 0110682 A GB0110682 A GB 0110682A GB 0110682 D0 GB0110682 D0 GB 0110682D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- once
- pharmaceutical composition
- composition containing
- day pharmaceutical
- containing brivudine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2001MI000009A ITMI20010009A1 (en) | 2001-01-03 | 2001-01-03 | PHARMACEUTICAL COMPOSITIONS CONTAINING BRIVUDINA FOR SINGLE DAILY ADMINISTRATION |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GB0110682D0 true GB0110682D0 (en) | 2001-06-20 |
| GB2370771A GB2370771A (en) | 2002-07-10 |
Family
ID=11446384
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB0110682A Withdrawn GB2370771A (en) | 2001-01-03 | 2001-05-01 | Once-a-day pharmaceutical composition comprising brivudine |
Country Status (20)
| Country | Link |
|---|---|
| AT (1) | AT6141U1 (en) |
| BE (1) | BE1014522A5 (en) |
| CH (1) | CH695662A5 (en) |
| CZ (1) | CZ20012464A3 (en) |
| DK (1) | DK177084B1 (en) |
| ES (1) | ES2192456B1 (en) |
| FI (1) | FI20011446A (en) |
| FR (1) | FR2818907B1 (en) |
| GB (1) | GB2370771A (en) |
| GR (1) | GR1004012B (en) |
| HR (1) | HRPK20010345B3 (en) |
| HU (1) | HUP0102816A3 (en) |
| IE (1) | IE20010413A1 (en) |
| IT (1) | ITMI20010009A1 (en) |
| NL (1) | NL1018431C2 (en) |
| PL (1) | PL348480A1 (en) |
| PT (1) | PT102642B (en) |
| SE (1) | SE0102309L (en) |
| SK (1) | SK287043B6 (en) |
| UA (1) | UA76402C2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113712928A (en) * | 2021-09-29 | 2021-11-30 | 重庆市力扬医药开发有限公司 | Brivudine drug absorbed through oral mucosa |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2239527B1 (en) * | 2004-03-01 | 2006-11-16 | M. Cruz Fernandez Gonzalez | PHARMACOLOGICAL COMPOSITION OF TOPICAL USE FOR THE TREATMENT OF HERPES ZOSTER. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0104857A1 (en) * | 1982-09-28 | 1984-04-04 | Beecham Group Plc | Deoxyuridine compounds, methods for preparing them and their use in medicine |
| IT1170232B (en) * | 1983-10-31 | 1987-06-03 | Anna Gioia Stendardi | THERAPEUTIC COMPOSITIONS WITH ANTI-VIRAL ACTIVITY |
| US5446031A (en) * | 1991-04-24 | 1995-08-29 | Yamasa Shuyu Kabushiki Kaisha | 1-β-D-arabinofuranosyl-(E)-5-(2-halogenovinyl)uracil derivatives |
| WO1997025989A1 (en) * | 1996-01-19 | 1997-07-24 | Glaxo Group Limited | Use of valaciclovir for the manufacture of a medicament for the treatment of genital herpes by a single daily application |
-
2001
- 2001-01-03 IT IT2001MI000009A patent/ITMI20010009A1/en unknown
- 2001-04-25 IE IE20010413A patent/IE20010413A1/en not_active IP Right Cessation
- 2001-05-01 GB GB0110682A patent/GB2370771A/en not_active Withdrawn
- 2001-05-11 HR HR20010345A patent/HRPK20010345B3/en not_active IP Right Cessation
- 2001-05-29 CH CH00987/01A patent/CH695662A5/en not_active IP Right Cessation
- 2001-06-28 SE SE0102309A patent/SE0102309L/en not_active Application Discontinuation
- 2001-06-29 FR FR0108596A patent/FR2818907B1/en not_active Expired - Lifetime
- 2001-06-29 DK DKPA200101019A patent/DK177084B1/en not_active IP Right Cessation
- 2001-07-02 NL NL1018431A patent/NL1018431C2/en not_active IP Right Cessation
- 2001-07-03 FI FI20011446A patent/FI20011446A/en not_active Application Discontinuation
- 2001-07-04 SK SK957-2001A patent/SK287043B6/en not_active IP Right Cessation
- 2001-07-04 BE BE2001/0452A patent/BE1014522A5/en not_active IP Right Cessation
- 2001-07-04 CZ CZ20012464A patent/CZ20012464A3/en unknown
- 2001-07-04 UA UA2001074658A patent/UA76402C2/en unknown
- 2001-07-05 PT PT102642A patent/PT102642B/en active IP Right Grant
- 2001-07-05 ES ES200101566A patent/ES2192456B1/en not_active Expired - Fee Related
- 2001-07-05 GR GR20010100322A patent/GR1004012B/en unknown
- 2001-07-05 HU HU0102816A patent/HUP0102816A3/en unknown
- 2001-07-05 PL PL01348480A patent/PL348480A1/en not_active Application Discontinuation
-
2002
- 2002-07-03 AT AT0805702U patent/AT6141U1/en not_active IP Right Cessation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113712928A (en) * | 2021-09-29 | 2021-11-30 | 重庆市力扬医药开发有限公司 | Brivudine drug absorbed through oral mucosa |
Also Published As
| Publication number | Publication date |
|---|---|
| ITMI20010009A0 (en) | 2001-01-03 |
| FR2818907B1 (en) | 2006-05-26 |
| ES2192456A1 (en) | 2003-10-01 |
| PT102642A (en) | 2002-07-31 |
| PL348480A1 (en) | 2002-07-15 |
| CZ20012464A3 (en) | 2002-08-14 |
| DK177084B1 (en) | 2011-07-11 |
| GB2370771A (en) | 2002-07-10 |
| FI20011446A (en) | 2002-07-04 |
| HRPK20010345B3 (en) | 2005-02-28 |
| AT6141U1 (en) | 2003-05-26 |
| DK200101019A (en) | 2002-07-04 |
| CH695662A5 (en) | 2006-07-31 |
| PT102642B (en) | 2003-06-30 |
| SE0102309L (en) | 2002-07-04 |
| IE20010413A1 (en) | 2003-04-16 |
| UA76402C2 (en) | 2006-08-15 |
| HUP0102816A2 (en) | 2002-10-28 |
| FI20011446A0 (en) | 2001-07-03 |
| HRP20010345A2 (en) | 2003-08-31 |
| FR2818907A1 (en) | 2002-07-05 |
| SE0102309D0 (en) | 2001-06-28 |
| SK9572001A3 (en) | 2003-03-04 |
| GR20010100322A (en) | 2002-10-08 |
| HUP0102816A3 (en) | 2005-01-28 |
| ES2192456B1 (en) | 2005-02-01 |
| SK287043B6 (en) | 2009-10-07 |
| HU0102816D0 (en) | 2001-09-28 |
| GR1004012B (en) | 2002-11-01 |
| ITMI20010009A1 (en) | 2002-07-03 |
| BE1014522A5 (en) | 2003-12-02 |
| NL1018431C2 (en) | 2002-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1450824A4 (en) | Pharmaceutical composition | |
| IL152659A0 (en) | Pharmaceutical composition | |
| HK1075889A1 (en) | Pharmaceutical composition | |
| PL367180A1 (en) | Stabilized oral pharmaceutical composition | |
| HUP0204555A3 (en) | Pharmaceutical composition | |
| HUP0303163A3 (en) | Tramadol-based pharmaceutical composition | |
| GB0117057D0 (en) | Pharmaceutical composition | |
| IL159722A0 (en) | Pharmaceutical compositions containing oligonucleotides | |
| HK1065257A1 (en) | Medicinal composition | |
| EP1408896A4 (en) | Pharmaceutical composition | |
| IL158236A0 (en) | Pharmaceutical compositions containing azithromycin and derivatives thereof | |
| GB0129117D0 (en) | Pharmaceutical composition | |
| IL154238A0 (en) | Pharmaceutical composition | |
| GB0116107D0 (en) | Pharmaceutical composition | |
| GB0127805D0 (en) | Pharmaceutical composition | |
| PL370037A1 (en) | Pharmaceutical composition | |
| GB0110682D0 (en) | Once-a-day pharmaceutical composition containing brivudine | |
| GB0114746D0 (en) | Medicinal composition | |
| HUP0402108A3 (en) | Macrolides containing pharmaceutical compositions | |
| GB0005382D0 (en) | Pharmaceutical composition | |
| IL157411A0 (en) | Pharmaceutical composition | |
| HU0103049D0 (en) | Pharmaceutical composition | |
| GB0125061D0 (en) | Pharmaceutical composition | |
| GB0101094D0 (en) | Pharmaceutical composition | |
| GB0002691D0 (en) | Pharmaceutical composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |